Pancreatic Cancer Research

ResearcherUniversity of MinnesotaActive in the last 2 years

David Masopust

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9440-3884; OpenAlex author ID A5050735501; NIH RePORTER profile ID 2541195. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
1
Labs led
0
Collaborators
11
Papers, trials and grants by year

2025: 1 grant · 2026: 1 paper

Papers 1

  1. Promoting tumor antigen presentation unleashes therapeutic efficacy of Tgfbr2-deficient TCR-engineered T cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2026-015489↗

Grants 1

  1. Project 1 P01CA254849↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paolo Provenzano · 1 shared paper, 1 shared grant, 2025–2026 · strength 0.96
  2. David J. Odde · 1 shared grant, 2025 · strength 0.73
  3. David Andrew Largaespada · 1 shared grant, 2025 · strength 0.73
  4. Ingunn M. Stromnes · 1 shared paper, 2026 · strength 0.23
  5. Adam L. Burrack · 1 shared paper, 2026 · strength 0.23
  6. Zoe C. Schmiechen · 1 shared paper, 2026 · strength 0.23
  7. Grant H. Hickok · 1 shared paper, 2026 · strength 0.23
  8. Alexander K. Tsai · 1 shared paper, 2026 · strength 0.23
  9. Guhan Qian · 1 shared paper, 2026 · strength 0.23
  10. Philip D. Greenberg · 1 shared paper, 2026 · strength 0.23
  11. Sunil R. Hingorani · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.